AQC Members Only - AI, Quality, and ICH E6(R3): From Principles to Practice
Wednesday, September 30, 2026, 10:00 AM - 2:00 PM
ICH E6(R3), Quality by Design, and AI: Framing Innovation Through a Risk-Based Lens
How ICH E6(R3) principles should shape AI implementation, ensuring AI-enabled processes support quality, risk management, oversight, and participant protection.
![]() |
Presenter: Karen Harvey Senior Director, Avoca Quality Consortium Avoca, A WCG Company |
Building AI Into the Foundation: Governance, Integration, and Sustainability
Practical approaches for embedding AI governance into existing quality and operational frameworks, including sustainability considerations and regulatory expectations.
![]() |
Speaker: Brian Barnes Director, Governance Excellence & Risk Management BioNTech |
From AI Curiosity to Inspection-Ready Quality Intelligence: Practical GenAI Practices for Clinical Development
![]() |
Presenter: Corey Alexander Global Head CQA Technologies, Innovation, and Operations Novartis |
Interactive Workshop Part 1: Applying AI to Protocol Design: A CTQ Identification Challenge
Participants review a protocol and identify CTQs and related risks. Discussion focuses on how AI can support protocol design, risk identification, and quality-by-design principles while maintaining appropriate oversight and accountability.
![]() |
Presenter: Jonathan Rowe Senior Consultant AQC |
Lunch Break
Interactive Workshop Part 2: Applying AI to Clinical Trial Processes: Risk, Oversight, and Gap Identification
Participants evaluate key clinical trial processes through an RBQM and oversight lens to identify process gaps, control weaknesses, and systemic risks. Discussion explores where AI can enhance efficiency and detection while supporting quality outcomes and inspection readiness.
![]() |
Presenter: Jonathan Rowe Senior Consultant AQC |
Joint Closing Session
Connecting the Dots: From Protocol Risk to Process Execution
Teams share findings from both exercises and discuss how CTQs, protocol-level risks, process controls, oversight activities, and AI-enabled insights work together to support quality and compliance under ICH E6(R3).
• Brian Barnes - Director, Governance Excellence & Risk Management - BioNTech
• Karen Harvey - Senior Director, Avoca Quality Consortium - Avoca, A WCG Company
• Jonathan Rowe, PhD, MS, MA - Senior Consultant - AQC



